Ivantis Inc. in Irvine closed on a $25 million Series C funding round for development and eventual marketing of a stent intended for use in glaucoma surgery. New investor RA Capital Management LLC in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results